Back to Agenda
Session 1: FDA Update on Combination Products
Session Chair(s)
Steven B. Binion
Director, Policy, Technology, and Communication - Corporate Regulatory Affairs
Becton Dickinson, United States
Leadership from the Office of Combination Products will provide an update on recent and pending activities at FDA. The discussion will address premarket and postmarket regulatory issues as well as agency systems and procedures to support a cross-cutting, collaborative approach to regulation of combination products.
Speaker(s)
FDA Update on Combination Products
Thinh X. Nguyen
FDA, United States
Director, Office of Combination Products, OCPP
Speaker
John Weiner, JD
FDA, United States
Associate Director for Policy, Office of Combination Products, OCPP, OC
Have an account?